The immunologic response to injury (Q74492380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

The immunologic response to injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

J A Mannick

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M L Rodrick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J A Lederer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Surgeons

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

237-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

Multiple organ failure. Pathophysiology and potential future therapy

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Dominance of T-helper 2-type cytokines after severe injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Burn injury primes naive CD4+ T cells for an augmented T-helper 1 response

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Injury primes the immune system for an enhanced and lethal T-cell response against bacterial superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Pentoxifylline attenuates pulmonary macromolecular leakage after intestinal ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Xanthine oxidase inhibition prevents mesenteric blood flow deficits after resuscitated hemorrhagic shock by preserving endothelial function

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Induction of T cell anergy by high concentrations of immunodominant native peptide is accompanied by IL-10 production and a block in JNK activity

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

The roles of CD28 and CD40 ligand in T cell activation and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Requirement and role of C5a in acute lung inflammatory injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Neutrophil activation in thermal injury as assessed by increased expression of complement receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Hypertonic saline infusion with or without dextran 70 in the reperfusion phase of experimental acute limb ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Hypertonic saline solution induces prostacyclin production by increasing cyclooxygenase-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

The role of prostaglandin E2 in immune suppression following injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Exogenous Human Recombinant Interleukin-10 Attenuates Hindlimb Ischemia–Reperfusion Injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Recombinant human manganese superoxide dismutase attenuates early but not delayed skeletal muscle dysfunction following reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Protective role of nitric oxide in ischemia and reperfusion injury of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Postoperative depression of the lymphocyte response to phytohaemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Association of Interleukin-4 Plasma Levels With Traumatic Injury and Clinical Course

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Melatonin Administration Following Hemorrhagic Shock Decreases Mortality from Subsequent Septic Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

1 reference

7 January 2021

Anti-interleukin-10 antibody restores burn-induced defects in T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Severe injury triggers antigen-specific T-helper cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

IFN-gamma decreases translocation and improves survival following transfusion and thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Prolactin: A Novel and Safe Immunomodulating Hormone for the Treatment of Immunodepression Following Severe Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Granulocyte–macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

Multiple-organ failure and sepsis without bacteria. An experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901011-0

7 January 2021

10.1016/S1072-7515(01)01011-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11548792%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference